Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-13

FDA Approved: OPTIONELLE — Supplemental Application (Strides Pharma Inc)

View source ↗

Summary

The FDA approved a supplemental application for OPTIONELLE (levonorgestrel tablet, 1.5 mg) from Strides Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPTIONELLE (LEVONORGESTREL TABLET, 1.5 MG)

Snippet

SUPPL AP for OPTIONELLE (LEVONORGESTREL TABLET, 1.5 MG)